Work

A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

Year: 2002

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: Giuseppe Giaccone, Cornelis J A Punt, Yoshitaka Ando, Rita Ruijter, Nobusuke Nishi, Marlies Peters, B Mary E von Blomberg, Rik J Scheper, Hans J J van der Vliet, Alfons J M van den Eertwegh, Marja Roelvink, Jos Beijnen, Heinz Zwierzina, Herbert M Pinedo

Institutions: Amsterdam UMC Location Vrije Universiteit Amsterdam, Radboud University Nijmegen, Kirin (Japan), Kirin Brewery Company, Limited (Japan), Vrije Universiteit Amsterdam, Slotervaartziekenhuis, Universität Innsbruck

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2116556475

FWCI: 6.937

Cites: 35

Cited by: 506

Related to: 10